Median PFS of women with ovarian cancers expressing low and medium levels of ERRγ was 1213 days compared to 714 days of women suffering from tumors with high expression of ERRγ (HR 1.78; 95% CI 1.12–2.96) (Fig. 4b). Here, ESRRG is linked to ovarian cancer.